Literature DB >> 14664466

Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia.

C M Isbister1, P J Mackenzie, D Anderson, N K Wade, J Oger.   

Abstract

We describe eight patients with associated multiple sclerosis (MS) and myasthenia gravis (MG). Patients were less than 50 years old at the time of onset, and seven were female. The clinical course of both MS and MG was mild in most patients. To our knowledge, this represents the largest reported series. We provide further evidence for a nonrandom association of these two diseases and discuss common mechanisms of pathogenesis.

Entities:  

Mesh:

Year:  2003        PMID: 14664466     DOI: 10.1191/1352458503ms964oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  11 in total

1.  Adult celiac disease with acetylcholine receptor antibody positive myasthenia gravis.

Authors:  Hugh J Freeman; Helen R Gillett; Peter M Gillett; Joel Oger
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

2.  Clinical characteristics of autoimmune disorders in the central nervous system associated with myasthenia gravis.

Authors:  Kimitoshi Kimura; Yoichiro Okada; Chihiro Fujii; Kenichi Komatsu; Ryosuke Takahashi; Sadayuki Matsumoto; Takayuki Kondo
Journal:  J Neurol       Date:  2019-07-24       Impact factor: 4.849

3.  Primary progressive multiple sclerosis and generalized myasthenia gravis: an uncommon association.

Authors:  G Bigliardi; J Mandrioli; F Valzania; P Nichelli; N Casula; A M Simone; P Sola
Journal:  Neurol Sci       Date:  2010-06-29       Impact factor: 3.307

4.  A patient with myasthenia gravis and a large arachnoid cyst - report of a case.

Authors:  Mira Bucuk; Iva Gasparovic; Ivan Sonnenschein; Olivio Perkovic
Journal:  Wien Klin Wochenschr       Date:  2017-02-22       Impact factor: 1.704

Review 5.  Cross-syndrome: myasthenia gravis and the demyelinating diseases of the central nervous system combination. Systematic literature review and case reports.

Authors:  Ekaterina Luzanova; Svetlana Stepanova; Nikita Nadtochiy; Elena Kryukova; Maria Karpova
Journal:  Acta Neurol Belg       Date:  2022-06-14       Impact factor: 2.396

6.  Myasthenia gravis development and crisis subsequent to multiple sclerosis.

Authors:  Kurosh Gharagozli; Maziar Shojaei; Ali Amini Harandi; Nayyereh Akbari; Manouchehr Ilkhani
Journal:  Case Rep Med       Date:  2011-05-18

Review 7.  Regulatory T cells in multiple sclerosis and myasthenia gravis.

Authors:  K M Danikowski; S Jayaraman; B S Prabhakar
Journal:  J Neuroinflammation       Date:  2017-06-09       Impact factor: 8.322

8.  A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis.

Authors:  Zisis Tsouris; Christos Liaskos; Efthymios Dardiotis; Thomas Scheper; Vana Tsimourtou; Wolfgang Meyer; George Hadjigeorgiou; Dimitrios P Bogdanos
Journal:  Auto Immun Highlights       Date:  2020-04-10

Review 9.  Myasthenia gravis: a clinical-immunological update.

Authors:  Sophie Binks; Angela Vincent; Jacqueline Palace
Journal:  J Neurol       Date:  2015-12-24       Impact factor: 4.849

10.  Cognitive impairment as a central cholinergic deficit in patients with Myasthenia Gravis.

Authors:  Antonia Kaltsatou; Dimitris Fotiou; Dimitris Tsiptsios; Anastasios Orologas
Journal:  BBA Clin       Date:  2015-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.